Telbivudine Versus Lamivudine in Chinese Adults With Compensated Chronic Hepatitis B

NCT00131742 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B

Interventions

DRUG: telbivudine
DRUG: lamivudine

Sponsor

Novartis

Collaborators

[object Object]